A. E. Pontiroli

690 total citations
30 papers, 549 citations indexed

About

A. E. Pontiroli is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, A. E. Pontiroli has authored 30 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 4 papers in Oncology. Recurrent topics in A. E. Pontiroli's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). A. E. Pontiroli is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (5 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). A. E. Pontiroli collaborates with scholars based in Italy, Austria and Germany. A. E. Pontiroli's co-authors include G. Pozza, M. Alberetto, Roberto Lanzi, Lucilla D. Monti, Antonino Morabito, Dario Giugliano, Katherine Esposito, Rita Paroni, P. Pizzocri and Paola Vedani and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Diabetologia.

In The Last Decade

A. E. Pontiroli

30 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Pontiroli Italy 14 267 122 122 97 68 30 549
M. Alberetto Italy 13 205 0.8× 116 1.0× 49 0.4× 127 1.3× 69 1.0× 26 540
Melanie Scott United States 15 313 1.2× 252 2.1× 133 1.1× 117 1.2× 76 1.1× 32 521
Neelima V. Chu United States 10 275 1.0× 130 1.1× 189 1.5× 262 2.7× 22 0.3× 11 649
Hillevi Larsson Sweden 11 551 2.1× 251 2.1× 169 1.4× 163 1.7× 43 0.6× 13 926
M. Komjati Austria 11 253 0.9× 221 1.8× 91 0.7× 159 1.6× 78 1.1× 25 471
Frederick H. Ziel United States 10 242 0.9× 75 0.6× 101 0.8× 183 1.9× 44 0.6× 10 504
Kota Matsuki Japan 16 255 1.0× 237 1.9× 54 0.4× 137 1.4× 54 0.8× 34 594
Taisuke Iwaoka Japan 14 242 0.9× 157 1.3× 94 0.8× 114 1.2× 39 0.6× 35 558
P. K. Dinda Canada 15 76 0.3× 156 1.3× 211 1.7× 142 1.5× 64 0.9× 48 646
V. Várró Hungary 12 63 0.2× 198 1.6× 105 0.9× 101 1.0× 40 0.6× 65 483

Countries citing papers authored by A. E. Pontiroli

Since Specialization
Citations

This map shows the geographic impact of A. E. Pontiroli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Pontiroli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Pontiroli more than expected).

Fields of papers citing papers by A. E. Pontiroli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Pontiroli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Pontiroli. The network helps show where A. E. Pontiroli may publish in the future.

Co-authorship network of co-authors of A. E. Pontiroli

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Pontiroli. A scholar is included among the top collaborators of A. E. Pontiroli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Pontiroli. A. E. Pontiroli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koivisto, Veikko A, Simon Cleall, A. E. Pontiroli, & Dario Giugliano. (2011). Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal‐bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open‐label trial. Diabetes Obesity and Metabolism. 13(12). 1149–1157. 11 indexed citations
2.
Pontiroli, A. E., et al.. (2011). Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta‐analysis. Diabetes Obesity and Metabolism. 14(5). 433–446. 38 indexed citations
3.
Pontiroli, A. E., P. Pizzocri, Paola Vedani, et al.. (2004). Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. European Journal of Endocrinology. 150(2). 195–200. 72 indexed citations
4.
5.
Fragasso, Gabriele, et al.. (1998). Imbalance between basal and insulin-stimulated endothelin release, nitric oxide release and muscle glucose metabolism in patients with syndrome X. Journal of the American College of Cardiology. 31. 85–86. 2 indexed citations
6.
Pontiroli, A. E., et al.. (1993). Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients. European Journal of Clinical Pharmacology. 45(6). 555–558. 26 indexed citations
7.
Pontiroli, A. E., et al.. (1993). Metabolic effects of graded glucagon infusions in man: Inhibition of glucagon, insulin, and somatostatin response to arginine. Metabolism. 42(10). 1242–1248. 5 indexed citations
8.
Pontiroli, A. E., et al.. (1993). Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.. PubMed. 19(1). 30–5. 4 indexed citations
9.
Pontiroli, A. E., et al.. (1991). Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget’s disease of bones: a pilot study. Journal of Endocrinological Investigation. 14(1). 47–51. 27 indexed citations
10.
Pontiroli, A. E., et al.. (1991). Growth Hormone (GH) Autofeedback on GH Response to GH-Releasing Hormone. Role of Free Fatty Acids and Somatostatin. The Journal of Clinical Endocrinology & Metabolism. 72(2). 492–495. 53 indexed citations
11.
Pontiroli, A. E., Roberto Lanzi, Lucilla D. Monti, & G. Pozza. (1990). Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects. Journal of Endocrinological Investigation. 13(6). 539–542. 39 indexed citations
12.
13.
Pontiroli, A. E., et al.. (1989). Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents. European Journal of Clinical Pharmacology. 37(4). 427–430. 47 indexed citations
14.
Pontiroli, A. E., Roberto Lanzi, & G. Pozza. (1989). Inhibition of the Growth Hormone (GH) Response to GH-Releasing Hormone by Constant Met-GH Infusions*. The Journal of Clinical Endocrinology & Metabolism. 68(5). 956–959. 15 indexed citations
15.
Pontiroli, A. E., et al.. (1988). Retinal laser photocoagulation in diabetic patients causes prolactin, growth hormone and cortisol release. Journal of Endocrinological Investigation. 11(5). 389–391. 1 indexed citations
16.
Pontiroli, A. E., et al.. (1987). Inhibition of Basal and Metoclopramide-Induced Prolactin Release by Cabergoline, an Extremely Long-Acting Dopaminergic Drug. The Journal of Clinical Endocrinology & Metabolism. 65(5). 1057–1059. 11 indexed citations
17.
Pontiroli, A. E., M. Alberetto, & G. Pozza. (1985). Intranasal calcitonin and plasma calcium concentrations in normal subjects.. BMJ. 290(6479). 1390–1391. 37 indexed citations
18.
Pontiroli, A. E.. (1985). Intranasal calcitonin and plasma calcium concentrations. BMJ. 291(6487). 54.3–55. 3 indexed citations
19.
20.
Pozza, G., J Traeger, J. M. Dubernard, et al.. (1983). Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia. 24(4). 244–8. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Alberetto Breakdown of academic impact, for papers by Melanie Scott Breakdown of academic impact, for papers by Neelima V. Chu Breakdown of academic impact, for papers by Hillevi Larsson Breakdown of academic impact, for papers by M. Komjati Breakdown of academic impact, for papers by Frederick H. Ziel Breakdown of academic impact, for papers by Kota Matsuki Breakdown of academic impact, for papers by Taisuke Iwaoka Breakdown of academic impact, for papers by P. K. Dinda Breakdown of academic impact, for papers by V. Várró
Rankless by CCL
2026